$CHTP News Wednesday’s movers: Herbalife slumps after

New Post Public Reply Private Reply Replies (0) Message Board

Jan 29, 2014 at 10:24 AM

$CHTP News

Wednesday’s movers: Herbalife slumps after call 4:57 p.m. Feb. 20, 2013 - Sue Chang
Chelsea Therapeutics CEO, other execs step down 6:17 a.m. July 10, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 12:00 p.m. May 31, 2012 - MarketWatch
Chelsea shares tumble on FDA setback 9:53 a.m. March 29, 2012 - MarketWatch.com
FDA seeks more info from Chelsea Therapeutics 7:22 a.m. March 29, 2012 - Greg Morcroft
Chelsea Therapeutics falls 23% in premarket 7:04 a.m. March 29, 2012 - Steve Gelsi
FDA decision nears for Chelsea Therapeutics 11:10 a.m. March 14, 2012 - MarketWatch.com
Friday’s biggest gaining and declining stocks 4:40 p.m. Feb. 24, 2012 - Kate Gibson
Chelsea Therapeutics soars on FDA nod 1:13 p.m. Feb. 24, 2012 - Val Brickates Kennedy
Chelsea Therapeutics up 71% in premarket 7:58 a.m. Feb. 24, 2012 - Steve Gelsi
Stocks to watch Friday: Deckers, Salesforce, Crocs 6:49 a.m. Feb. 24, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 4:51 p.m. Feb. 13, 2012 - MarketWatch
Chelsea plunges 36% ahead of FDA update 10:54 a.m. Feb. 13, 2012 - Val Brickates Kennedy
Chelsea Therapeutics jumps 8% on ADHD study 11:15 a.m. July 26, 2011 - Val Brickates Kennedy
Biogen, Acura lead drug stocks north 2:54 p.m. June 20, 2011 - Val Brickates Kennedy
Friday’s biggest advancing & declining stocks 2:55 p.m. June 10, 2011 - Kate Gibson
Drug stocks follow broader market south 12:10 p.m. June 10, 2011 - Val Brickates Kennedy
Chelsea Therapeutics soars on price target upgrade 9:01 a.m. June 10, 2011 - Val Brickates Kennedy
Monday’s biggest advancing and declining stocks 12:27 p.m. April 18, 2011 - MarketWatch
Wednesday’s biggest gaining and declining stocks 6:05 p.m. Feb. 2, 2011 - Kate Gibson

Does Accuray's Recent Unusual Bullish Options Activity Signal A Rally In The Stock Soon? 7:50 a.m. Jan. 28, 2014 - Seeking Alpha
Telecom Industry Stock Outlook - Jan 2014 - Zacks Analyst Interviews 5:37 a.m. Jan. 21, 2014 - Zacks.com
Telecom Industry Stock Outlook - Jan 2014 - Industry Outlook 5:37 a.m. Jan. 21, 2014 - Zacks.com
J.P. Morgan Confab Focus Reminds Us Upside Remains In Biotech 3:30 p.m. Jan. 17, 2014 - TheStreet.com
A Few Minutes With Chelsea's CEO on Tuesday's Northera Panel and Future Plans 10:33 a.m. Jan. 17, 2014 - TheStreet.com
Stocks You Wish You Owned on January 15 10:42 p.m. Jan. 16, 2014 - WallStreetSectorSelector
Chelsea Therapeutics May Be A Revenue Generating Biotech By The End Of 2014 3:02 p.m. Jan. 16, 2014 - Seeking Alpha
Company news for January 16, 2014 - Corporate Summary 10:06 a.m. Jan. 16, 2014 - Zacks.com
Chelsea Therapeutics International (CHTP) Soars: Stock Up 91.7% - Tale of the Tape 9:39 a.m. Jan. 16, 2014 - Zacks.com
FDA Panel Backs CHTP's Northera - Analyst Blog 6:10 p.m. Jan. 15, 2014 - Zacks.com
Can Chelsea Live Up to Its Potential This Time? 11:20 a.m. Jan. 15, 2014 - 247WallSt.com
2 Biotech Stocks in Play: Celsion and Chelsea 11:14 a.m. Jan. 15, 2014 - Wall St. Cheat Sheet
Sell-side weighs in as Chelsea Therapeutics soars 9:40 a.m. Jan. 15, 2014 - Seeking Alpha
Biotech Stock Roundup: Intercept Pharma Grabs the Limelight - Analyst Blog 9:31 a.m. Jan. 15, 2014 - Zacks.com
Morning Market Movers 8:54 a.m. Jan. 15, 2014 - benzinga.com
Top Analyst Upgrades and Downgrades: Intel, ExOne, GameStop, SodaStream and More 8:00 a.m. Jan. 15, 2014 - 247WallSt.com
Chelsea Therapeutics' Northera Gets Strong Support From FDA Panel 7:58 a.m. Jan. 15, 2014 - WSJ.com
Chelsea Therapeutics soars on outlook for Northera 7:50 a.m. Jan. 15, 2014 - Seeking Alpha
CHTP Stock – Chelsea Therapeutics Passes FDA Test, Stock Skyrockets 5:19 a.m. Jan. 15, 2014 - InvestorPlace.com
5 Biotech Stocks With Big Catalysts on the Horizon 3:26 a.m. Jan. 15, 2014 - InvestorPlace.com

Real Good Solar Takes On New Name, Ticker Symbol and Strategy: Real Goods Solar Inc. (NASDAQ:RSOL), Atossa Genetics Inc. (NASDAQ: ATOS), Chelsea Therapeutics International, Ltd. (NASDAQ:CHTP) 8:02 a.m. Jan. 28, 2014 - ACCESSWIRE
Chelsea Therapeutics Announces Joseph G. Oliveto Named President and Chief Executive Officer, Director 7:00 a.m. Jan. 27, 2014 - GlobeNewswire
Early 2014 Advancing Companies with Expansion & New Distribution Opportunities: RiceBran, Whole Foods, Hain Celestial, DryShips and Chelsea Therapeutics 9:05 a.m. Jan. 16, 2014 - PR Newswire - PRF
Opening Buzzers: Chelsea Therapeutics International, Tesla Motors Inc, NQ Mobile Inc, Rexahn Pharmaceuticals 11:02 a.m. Jan. 15, 2014 - ACCESSWIRE
FDA Advisory Panel Recommends Approval of Chelsea Therapeutics' NORTHERA(TM) (Droxidopa) for the Treatment of Symptomatic nOH 5:09 p.m. Jan. 14, 2014 - GlobeNewswire
Healthcare Companies Report Petition Submission, Pricing of Follow-On Offerings and Stock Price Movements - Research Report on Johnson & Johnson, GW Pharma, Conatus Pharma, Chelsea, and Insmed 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Clinical Findings Presentations, Stock Price Movements, and Addition to Indexes - Research Report on Acceleron, AcelRx, Antares, Chelsea Therapeutics, and Clovis 8:00 a.m. Jan. 6, 2014 - PR Newswire
Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics 8:00 a.m. Dec. 24, 2013 - PR Newswire
Health Care Sector Insights: ZIOPHARM Oncology, Chelsea Therapeutics Intl., Antares Pharma, and Accuray 8:34 a.m. Dec. 19, 2013 - PR Newswire
Chelsea Therapeutics Announces First Patient Dosed in NORTHERA(TM) (droxidopa) Study 401 for the Treatment of Symptomatic nOH 7:00 a.m. Dec. 9, 2013 - GlobeNewswire
Today's Research: ZIOPHARM Oncology Inc., Antares Pharma Inc., Chelsea Therapeutics Intl. Ltd, and Accuray Inc. 1:29 p.m. Nov. 22, 2013 - PR Newswire
Study Results, Private Placements, Collaborations, Product Launches, and Public Offerings - Research Report on ViroPharma, Incyte, Tenet Healthcare, Sagent Pharmaceuticals and Chelsea Therapeutics 8:00 a.m. Nov. 22, 2013 - PR Newswire
Chelsea Therapeutics Completes Public Offering of Common Stock 10:32 a.m. Nov. 18, 2013 - GlobeNewswire
BBEP, CHTP, XGTI and SNTA added to NASDAQ Active Stock Watch List at GSR 10:33 a.m. Nov. 13, 2013 - ACCESSWIRE
Chelsea Therapeutics Announces Pricing of Public Offering of Common Stock 8:45 a.m. Nov. 13, 2013 - GlobeNewswire
Chelsea Therapeutics Announces Public Offering of Common Stock 5:50 p.m. Nov. 12, 2013 - GlobeNewswire
Chelsea Therapeutics Reports Third Quarter 2013 Financial Results 4:23 p.m. Nov. 5, 2013 - GlobeNewswire
Morning Research: Antares Pharma Inc., Chelsea Therapeutics Intl. Ltd, Accuray Inc., and ZIOPHARM Oncology Inc. 8:11 a.m. Oct. 30, 2013 - PR Newswire
Chelsea Therapeutics Announces FDA Advisory Committee to Review NORTHERA(TM) (droxidopa) 3:01 p.m. Oct. 9, 2013 - GlobeNewswire
Early Briefing and Review: Accuray Inc., Chelsea Therapeutics Intl. Ltd, ZIOPHARM Oncology Inc., and Antares Pharma Inc. 8:40 a.m. Oct. 8, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MSP360 Unveils Free Proxmox Backup: A Game Changer?

Backing Up: New Paths for Proxmox Users Ever get that feeling of uncovering something truly worth its weight in gold? That's what MSP360 just dropped on us, with their new backup solution for Proxmox that won’t cost you a dime upfront. They're calling it the Community Edition, and it’s not only free, but it comes with all the bells and whistles for protecting those...

Cabot Wilds: Nova Scotia's Next Luxury Golf Haven

Breaking New Ground in Golf and Luxury Cabot and the Bragg family are cooking up something extraordinary in Cumberland County, Nova Scotia. The new luxury lifestyle and golf destination, Cabot Wilds, promises to be more than just a retreat—it's a bold statement on how to marry nature, luxury, and community. Set to open in late 2027, this expansive 2,500-acre resort will...

Inovonics Duress Card Enhances Safety for K-12 and Beyond

A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...

Mutare Sharpens Security for Webex Calls with Precision

Control Dialed In: Tailored Call Screening Kicking things up a notch, Mutare is redefining call security by fine-tuning their Voice Security for Webex Calling. Imagine this—custom rules now let organizations shape a security policy down to the very last detail, ensuring unwanted calls don’t slip through the cracks. Wave goodbye to the broad-strokes approach. Precision...

FC2 Condom Educates NYC on Health and Wellness

Union Square Becomes a Hub of Interactivity The heart of NYC pulsed with purpose as FC2 Female Condom set up shop in Union Square, using the iconic location as a stage for a different kind of celebration. Clear Future, the manufacturer behind FC2, marked Global Female Condom Day with an event unlike any other. It wasn't just about the product—it was a call to educate...

MasterBrand's 2027 Kitchen Trends: Embrace Warmth

Wood Finishes and the Warm Embrace Alright folks, let's cut through the fluff and get to the heart of the matter: wood finishes are making a roaring comeback in 2027 kitchens. And it's not just some passing phase, we're talking a comprehensive shift toward warmer and more natural kitchen designs. MasterBrand, Inc. isn't just throwing darts at a board here. They surveyed a...

RxWellness Hits Inc. 5000—Four Straight Wins Impress

RxWellness Spine & Health Continues to Impress Well, not many companies can boast about snagging a spot on the Inc. 5000 list four years in a row, but here we are with RxWellness Spine & Health doing just that. Sitting pretty at No. 1,230 nationally—and that's no small feat—these folks are making waves in the healthcare industry. Securing the No. 135 spot in...

Perk's U.S. Expansion: A Bold Move in Spend Control

Perk Aims for U.S. Growth: Will It Pay Off? Amidst the cacophony of market chatter, Perk's announcement to bring its spend platform stateside is echoing louder than usual. This move is not just another step in its expansion but rather a leap considering the competition and market needs. In Europe, where they've already captured a chunk of the market with their Travel and...

Lumicell Expands LumiSystem in Breast Cancer Surgery

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

TWP & Commbi Unveil Exclusive Pony Clog Collaboration

A Fusion of Fashion and Functionality Walk down the streets of New York or hustle your way through an airport without worrying about your footwear weighing you down. That's the promise coming from the fresh alliance between TWP and Commbi with their new Pony Clog Collaboration. A blend of high fashion and everyday utility, these clogs aren't just keeping up with the...